Related Experiment Video
Updated: Dec 28, 2025
05:31
Isolation, Cryopreservation and Culture of Human Amnion Epithelial Cells for Clinical Applications
Published on: December 21, 2014
14.3K
Amniotic Product Treatments: Clinical and Basic Science Evidence.
Hailey P Huddleston1, Matthew R Cohn1, Eric D Haunschild1
1Department of Orthopaedic Surgery, Division of Sports Medicine, Rush University Medical Center, 1611 W. Harrison St, Suite 300, Chicago, IL, 60612, USA.
Current Reviews in Musculoskeletal Medicine
|February 21, 2020
Summary
Amniotic products show promise for orthopedic conditions like osteoarthritis in animal studies, but human clinical trials are limited and show mixed results. More research is needed to confirm their effectiveness and safety in patients.
Area of Science:
- Orthopedics
- Regenerative Medicine
- Biologics
Background:
- Orthobiologics, including amniotic products, are increasingly explored for orthopedic conditions like osteoarthritis.
- The use of biologics in orthopedics currently lacks comprehensive oversight and regulation.
- Amniotic products are a focus of interest due to their potential therapeutic properties.
Purpose of the Study:
- To review the current research on amniotic products used in orthopedic treatments.
- To assess the in vitro and in vivo evidence for amniotic product efficacy.
- To evaluate the existing clinical data and identify research gaps.
Main Methods:
- Literature review of in vitro and in vivo studies on amniotic products.
- Analysis of preclinical animal models investigating amniotic product effects.
- Examination of available human clinical trial data, noting limitations and outcomes.
Main Results:
- Amniotic tissue derivatives demonstrate positive effects in various animal models.
- Clinical trials investigating amniotic products for orthopedic conditions are limited.
- Outcomes from existing human studies are mixed, suggesting a need for further investigation.
Conclusions:
- Amniotic products show potential in numerous preclinical studies for orthopedic applications.
- Robust human clinical trials are currently lacking to support widespread use.
- Future research should focus on rigorous clinical evaluation to determine the role of amniotic products in treating osteoarthritis and other orthopedic pathologies.
